Aptevo
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aptevo and other ETFs, options, and stocks.About APVO
Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527, and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology.
APVO Key Statistics
Stock Snapshot
With a market cap of 3.05M, Aptevo(APVO) trades at $1.70. The stock has a price-to-earnings ratio of -0.05.
On 2026-09-03, Aptevo(APVO) stock traded between a low of $1.37 and a high of $2.68. Shares are currently priced at $1.70, which is +24.1% above the low and -36.6% below the high.
The Aptevo(APVO)'s current trading volume is 1.69M, compared to an average daily volume of 154.72K.
In the last year, Aptevo(APVO) shares hit a 52-week high of $48.78 and a 52-week low of $1.37.
In the last year, Aptevo(APVO) shares hit a 52-week high of $48.78 and a 52-week low of $1.37.
APVO News
Aptevo Therapeutics Inc. (NASDAQ:APVO) announced that its lead candidate mipletamig achieved a 93% clinical benefit rate when administered as a triplet therapy...
Aptevo Therapeutics ( (APVO) ) just unveiled an announcement. On September 3, 2026, Aptevo Therapeutics reported new data showing a 93% clinical benefit rate f...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.